| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1011200458 |
| P356 | DOI | 10.1186/1471-2407-8-238 |
| P932 | PMC publication ID | 2527332 |
| P698 | PubMed publication ID | 18702824 |
| P5875 | ResearchGate publication ID | 23170545 |
| P50 | author | Cláudia A Rainho | Q64437975 |
| Daisy Maria Fávero Salvadori | Q90811994 | ||
| P2093 | author name string | Priscilla D Negraes | |
| Francine P Favaro | |||
| José Goldberg | |||
| João Lauro V Camargo | |||
| Maria Luiza C S Oliveira | |||
| P2860 | cites work | Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? | Q22251049 |
| Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression | Q24291194 | ||
| DNA methylation profiling of human chromosomes 6, 20 and 22 | Q24607522 | ||
| Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands | Q24631957 | ||
| Worms gang up on bacteria | Q27860588 | ||
| Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients | Q28156141 | ||
| The tumor suppressor gene 14-3-3 sigma is commonly methylated in normal and malignant lymphoid cells | Q28208792 | ||
| Functional epigenomics identifies genes frequently silenced in prostate cancer | Q28251350 | ||
| Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel | Q28252481 | ||
| Emerging molecular markers of cancer. | Q30330271 | ||
| Retinoic acid receptors and cancers. | Q30341794 | ||
| Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. | Q53360022 | ||
| Hypermethylation of an E-cadherin (CDH1) promoter region in high grade transitional cell carcinoma of the bladder comprising carcinoma in situ. | Q54785022 | ||
| The fundamental role of epigenetic events in cancer | Q56421597 | ||
| Changes in DNA Methylation Patterns in Subjects Exposed to Low-Dose Benzene | Q57208389 | ||
| Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas | Q57794449 | ||
| Frequent hypermethylation of promoter region ofRASSF1A in tumor tissues and voided urine of urinary bladder cancer patients | Q59313568 | ||
| Genomic instability analysis of urine sediment versus tumor tissue in transitional cell carcinoma of the urinary bladder | Q61414847 | ||
| Loss of P16 Expression and Chromosome 9p21 LOH in Predicting Outcome of Patients Affected by Superficial Bladder Cancer | Q62660604 | ||
| Tumor suppressor genes | Q68264184 | ||
| Rapid silver staining and recovery of PCR products separated on polyacrylamide gels | Q72495882 | ||
| Genome-wide genetic characterization of bladder cancer: a comparison of high-density single-nucleotide polymorphism arrays and PCR-based microsatellite analysis | Q73344262 | ||
| Clinical significance of allelotype profiling for urothelial carcinoma | Q73739771 | ||
| Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR | Q73852496 | ||
| Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer | Q74088944 | ||
| Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer | Q74256215 | ||
| Frequent hypermethylation of the 5' CpG island of E-cadherin in esophageal adenocarcinoma | Q74509263 | ||
| Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis | Q77220460 | ||
| Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features | Q77372414 | ||
| A partial allelotyping of urothelial carcinoma of bladder in the Chinese | Q79266990 | ||
| Age-related DNA methylation changes in normal human prostate tissues | Q80557757 | ||
| Analysis of genetic events in 17p13 and 9p21 regions supports predominant monoclonal origin of multifocal and recurrent bladder cancer | Q81605764 | ||
| C-erb-2 gene amplification and chromosomal anomalies in bladder cancer: preliminary results | Q82525141 | ||
| CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer | Q33235269 | ||
| Quantitative promoter methylation analysis of multiple cancer-related genes in renal cell tumors | Q33291459 | ||
| CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future | Q33337445 | ||
| Cell adhesion system and human cancer morphogenesis | Q34211371 | ||
| Evolution of colorectal cancer: change of pace and change of direction. | Q34622521 | ||
| CpG island methylation in aberrant crypt foci of the colorectum | Q35748049 | ||
| High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer | Q35759154 | ||
| Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma | Q35788760 | ||
| The tumor suppressor RASSF1A in human carcinogenesis: an update | Q36056924 | ||
| The pathology of bladder cancer | Q36418383 | ||
| Assessing the effects of high methionine intake on DNA methylation | Q36479628 | ||
| Environmental and nutritional effects on the epigenetic regulation of genes | Q36541062 | ||
| Tumor suppressor loci in bladder cancer | Q36664793 | ||
| Role of retinoids and their cognate nuclear receptors in breast cancer chemoprevention | Q36816635 | ||
| Gene methylation and early detection of genitourinary cancer: the road ahead | Q36856466 | ||
| Cancer genetics of epigenetic genes | Q36871595 | ||
| Unraveling the epigenetic code of cancer for therapy | Q36903205 | ||
| BCL6 gene mutations in transitional cell carcinomas | Q38301198 | ||
| Urea improves efficiency of bisulphite-mediated sequencing of 5'-methylcytosine in genomic DNA | Q39725464 | ||
| Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection | Q40306062 | ||
| Bladder cancer outcome and subtype classification by gene expression | Q40414408 | ||
| Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients | Q40486848 | ||
| The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee | Q40831782 | ||
| Replicative senescence: implications for in vivo aging and tumor suppression | Q41003046 | ||
| Formation of methylation patterns in the mammalian genome | Q41439635 | ||
| Nucleic acid-based methods for the detection of cancer | Q41628883 | ||
| Sun exposure related methylation in malignant and non-malignant skin lesions | Q42491211 | ||
| Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals | Q42856300 | ||
| Accelerated age-related CpG island methylation in ulcerative colitis | Q43828587 | ||
| CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer | Q44039920 | ||
| Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples | Q44488217 | ||
| CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer | Q44903620 | ||
| Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer | Q45181407 | ||
| Bladder cancer: epidemiology, staging and grading, and diagnosis. | Q45247416 | ||
| A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer | Q45873847 | ||
| Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma. | Q45993982 | ||
| Carcinogen exposure and gene promoter hypermethylation in bladder cancer | Q46575036 | ||
| Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes | Q46698575 | ||
| Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors | Q47392541 | ||
| Epigenetic control of the E-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis | Q47430803 | ||
| Genetic instability in superficial bladder cancer and adjacent mucosa: an interphase cytogenetic study. | Q47996049 | ||
| Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder. | Q52933247 | ||
| Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas. | Q53342173 | ||
| Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma. | Q53346892 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bladder cancer | Q504775 |
| DNA methylation | Q874745 | ||
| P304 | page(s) | 238 | |
| P577 | publication date | 2008-08-14 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | DNA methylation patterns in bladder cancer and washing cell sediments: a perspective for tumor recurrence detection | |
| P478 | volume | 8 |
| Q34346375 | Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers |
| Q35827925 | Comparative analysis of 14-3-3 isoform expression and epigenetic alterations in colorectal cancer |
| Q28386699 | Convergence of nanotechnology and cancer prevention: are we there yet? |
| Q38833395 | DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects. |
| Q34249360 | DNA Methylation profiles as predictors of recurrence in non muscle invasive bladder cancer: an MS-MLPA approach. |
| Q34756518 | Diagnostic markers of urothelial cancer based on DNA methylation analysis. |
| Q90362351 | Effects of Propolis and Phenolic Acids on Triple-Negative Breast Cancer Cell Lines: Potential Involvement of Epigenetic Mechanisms |
| Q38201500 | Evaluation of diagnostic accuracy of DNA methylation biomarkers for bladder cancer: a systematic review and meta-analysis |
| Q38414652 | Gene-specific promoter methylation is associated with micronuclei frequency in urothelial cells from individuals exposed to organic solvents and paints |
| Q37978544 | Hypermethylation in bladder cancer: biological pathways and translational applications |
| Q36055579 | Identification of gene signatures and molecular markers for human lung cancer prognosis using an in vitro lung carcinogenesis system |
| Q54384407 | Methylation analysis of cancer-related genes in non-neoplastic cells from patients with oral squamous cell carcinoma. |
| Q31058055 | Methylcap-seq reveals novel DNA methylation markers for the diagnosis and recurrence prediction of bladder cancer in a Chinese population |
| Q53063306 | Prediction of recurrence of non muscle-invasive bladder cancer by means of a protein signature identified by antibody microarray analyses. |
| Q57556278 | Promoter hypermethylation in primary squamous cell carcinoma of the oral cavity and oropharynx: a study of a Brazilian cohort |
| Q37656296 | Quantitative assessment of the relationship between RASSF1A gene promoter methylation and bladder cancer (PRISMA). |
| Q34471940 | The association of RAS association domain family Protein1A (RASSF1A) methylation states and bladder cancer risk: a systematic review and meta-analysis |
Search more.